Integer Holdings Opens Convertible Note Period as It Expands Medtech Operations in Ireland
PLANO, Texas October 2, 2024 Integer Holdings Corporation (NYSE: ITGR), a renowned entity in the medical device contract development and manufacturing sector, has unveiled significant developments concerning its 2.125% Convertible Senior Notes due 2028.This forward-looking announcement underscores the firm’s continued commitment to providing value to its stakeholders while expanding its global footprint.
The company has officially notified holders of the Convertible Senior Notes that they may opt to convert their Notes beginning on October 1, 2024, until the end of business on December 31, 2024.These Notes offer a conversion option that allows holders to convert their Notes into cash up to the principal amount.For any conversion obligation exceeding the principal amount, Integer retains the option to settle in cash, shares of the company’s common stock, or a combination of both.
This announcement signifies Integer’s strategic financial flexibility and reinforces confidence among investors regarding the company’s fiscal management and future growth trajectories.The flexibility in conversion options provided reinforces the company’s robust financial health and enhances investor confidence.Any future periods of convertibility for these Notes will be determined in line with the terms specified in the governing Indenture.
Parallel to its financial flexibility, Integer Holdings is amplifying its manufacturing capabilities and market presence globally.On September 23, 2024, the company announced a significant bolstering of its medtech operations through the establishment of a new facility in Ireland.This strategic expansion not only highlights Integer’s growth within the European market but also underscores its commitment to better serving its global clientele.
The Irish facility’s inauguration is a critical milestone in Integer’s strategic mission to fortify its supply chain and enhance its capabilities in the medtech sector.With this expansion, Integer aims to leverage Ireland’s favorable business environment and robust infrastructure to streamline operations and expedite product delivery across Europe and other international markets.
Tom Hook, Integer’s CEO, expressed enthusiasm about these developments, emphasizing how the Irish facility further cements Integer’s status as a leading player in the medtech sphere.Our expansion in Ireland is a testament to our relentless pursuit of excellence and our commitment to providing innovative solutions to our customers worldwide, Hook stated.By enhancing our global infrastructure, we are better positioned to meet the evolving needs of the medical device industry and drive value for our shareholders.
This dual announcement the convertibility of senior notes and the expansion in Ireland represents a holistic approach by Integer Holdings to reinforce its market position, ensure financial flexibility, and showcase its operational prowess on a global scale.
Comments